Connect with us at DCAT Week 2025
Leverage our 50 years of experience and integrated CDMO solutions for the success of your project
At Rentschler Biopharma, reliability you can trust is more than a promise—it's our commitment. As a global leader in CDMO services for biopharmaceuticals, including advanced therapies, we take pride in our contributions to nearly 25% of FDA-approved biopharmaceuticals in 2023.
We are looking forward to seeing you at DCAT Week 2025
Suite: 1104
Date: March 17-20, 2025
Location: Hotel 48 Lex, 517 Lexington Ave, New York City
Connect with our team at the event
Benedikt von Braunmühl
Chief Executive Officer
Christiane Bardroff
Chief Operating Officer
Discover our Service Portfolio
We offer integrated CDMO solutions for biologics customized to your needs - from process development to clinical and commercial manufacturing.
Press and Media Requests
Our Communications Team is happy to answer your questions and give you updates about the latest developments at our company.
Get in Touch with our Business Development Team
Are you interested in learning more? We look forward to hearing from you.